A detailed history of Twin Securities, Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Twin Securities, Inc. holds 28,559 shares of AXNX stock, worth $2.03 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares
28,559
Previous 16,059 77.84%
Holding current value
$2.03 Million
Previous $1.08 Million 84.34%
% of portfolio
2.25%
Previous 0.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $841,250 - $870,875
12,500 Added 77.84%
28,559 $1.99 Million
Q2 2024

Aug 14, 2024

SELL
$66.47 - $69.65 $1.15 Million - $1.21 Million
-17,355 Reduced 51.94%
16,059 $1.08 Million
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $1.89 Million - $2.32 Million
33,414 New
33,414 $2.3 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Twin Securities, Inc. Portfolio

Follow Twin Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Twin Securities, Inc. with notifications on news.